Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02899117 · ClinicalTrials.gov registry record · NA

Yoga Intervention to Improve Pediatric Cancer Patients' Sleep & Life Quality and Parents' Well-Being

A NA study of Neoplasms, sponsored by Connecticut Children's Medical Center.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT02899117: Completed NA study of Neoplasms, sponsored by Connecticut Children's Medical Center.

NCT02899117 is a NA study of Neoplasms that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 23 participants, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02899117, a NA study of Neoplasms, has completed, sponsored by Connecticut Children's Medical Center.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The proposed project will examine feasibility and preliminary efficacy of a yoga intervention in the pediatric oncology unit at Connecticut Children's Medical Center (CCMC) and includes two parts: (1) a survey of children and parents regarding preferences (e.g., convenient days/times), experiences and expectations regarding yoga (including barriers and positive expectancies) and (2) an eight week clinical trial of a yoga intervention in 10 pairs of children and parents.

Primary Outcome

The data will be assessed on perceived barriers/solutions.

Conditions Studied

Interventions

  • OTHER Yoga

Study Locations (1)

Connecticut

  • Connecticut Children's Medical Center - Hartford

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2014-08
Est. Completion 2017-01
Phase NA

What the finished NCT02899117 record still lists

NCT02899117 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Yoga is the first listed.

NCT02899117 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT02899117 about?

NCT02899117 is a clinical study titled "Yoga Intervention to Improve Pediatric Cancer Patients' Sleep & Life Quality and Parents' Well-Being". The proposed project will examine feasibility and preliminary efficacy of a yoga intervention in the pediatric oncology unit at Connecticut Children's Medical Center (CCMC) and includes two parts: (1) a survey of children and parents regarding preferences (e.g., convenient days/times), experiences a...

What is the current status of trial NCT02899117?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2014-08. Estimated completion is 2017-01.

What conditions does trial NCT02899117 study?

This clinical trial studies the following conditions: Neoplasms.

What interventions are being tested in trial NCT02899117?

The interventions under investigation include: Yoga (OTHER).

Who is sponsoring clinical trial NCT02899117?

This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02899117 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02899117's enrollment target sits among peer trials

23 142nd of 158 higher than 15 of 158 other Neoplasms trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02899117, the US trial registry maintained by the National Library of Medicine. NCT02899117 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.